Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
about
Known glioma risk loci are associated with glioma with a family history of brain tumours--a case-control gene association studyGenome-wide association study of glioma and meta-analysisA subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traitsMolecular functions and cellular roles of the ChlR1 (DDX11) helicase defective in the rare cohesinopathy Warsaw breakage syndromeRTEL1 (regulator of telomere elongation helicase 1), a DNA helicase essential for genome stabilityThe MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomideTelomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysisMolecular Markers in Low-Grade Glioma-Toward Tumor ReclassificationThe Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International ConsortiumAssociation between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control StudyUnderstanding inherited genetic risk of adult glioma - a reviewTERT promoter mutations and polymorphisms as prognostic factors in primary glioblastomaAdult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trendsCCDC26 rs4295627 polymorphism and glioma risk: a meta-analysisFunctional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibilitySSBP2 variants are associated with survival in glioblastoma patientsSurvival and low-grade glioma: the emergence of genetic informationDemographic variation in incidence of adult glioma by subtype, United States, 1992-2007.Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.Brain tumor risk according to germ-line variation in the MLLT10 locus.A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome.Biomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma.Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls.DNA helicases involved in DNA repair and their roles in cancerAn exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome.Rare TP53 genetic variant associated with glioma risk and outcome.Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.Prediagnostic body weight and survival in high grade glioma.Circadian pathway genes in relation to glioma risk and outcome.The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis.The role of the RTEL1 rs2297440 polymorphism in the risk of glioma development: a meta-analysis.An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.Assessment of glioma risk associated with an inherited variant at chromosome 11q23.Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.Performance of adjuvant treatment correlates with survival in reoperated glioblastomas.Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population.Rare and uncommon genetic variants may hold key to the 'missing heritability' in glioma.Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis.
P2860
Q23910347-FC25597E-3BAA-4FE2-A2D9-E72620E70E48Q23919638-DDF6187E-3D54-4AA5-B858-C24169456E8CQ24169696-458533DF-54FA-4DFD-AF80-F31CAD296CF4Q27016169-2DF6EF9C-BBB9-4228-B416-25D7F05A6066Q27026906-3DCF5F46-3734-4E2F-9773-40474D86907EQ27853156-07793978-0D03-43F8-BF03-08FB1B305D27Q28265076-BFCD8F8E-4B59-46C8-A947-E182F42074E0Q28383205-CC244285-971F-4A2D-B0B9-A48915683863Q28383443-7D958E92-0CC2-4414-A2E8-FA59528EEDECQ28383907-241E114D-C7FB-4A61-9698-94C954697B58Q28388566-CD7491C8-B1F9-47CA-9A83-11271A0F6750Q28390726-29C4EB64-2735-4ACE-AF10-A6E866E1A16DQ28393814-66D3FFEA-02DC-488B-A3C0-FB8075B7F8F1Q28394804-59E06BF8-2457-4E17-B41E-BBD6D1C2C55BQ28394851-27FE1EA2-348A-42C4-8492-0479B2696FD2Q28943446-CAC94933-EC9D-4D26-8CE6-A98E366A3271Q30395017-3EEAE930-35B6-4717-9356-F1DBF30E17A1Q33975580-9E2A1E53-0E29-474D-8BA6-9AC89ABAE52BQ34650062-65105732-792B-4298-A771-4FF4BC349BBEQ34705193-CB52FE52-8862-4D1B-AB4D-F35CA29B6106Q34979383-82B11A44-50F3-47AE-ABA7-2A057BF83630Q35026718-35381D33-FBE4-4E0A-8242-353DD887D804Q35552628-B2126FC9-FB76-45D3-A975-F6608F1FC670Q35652709-000DDEE0-F8A6-48F9-A56B-502A003DEC62Q35961508-994AE188-7A68-41DC-8E69-BA1BF1AEDADEQ36583954-D0B4CD66-DF27-4190-A12C-428BC5AFEAE3Q36622832-2344A875-528E-4D4F-AD7A-1087930B9C90Q36691743-E2374F5B-7991-4C6F-80AE-2C63373718DAQ36792729-1383B13C-9AB5-4EF7-9850-241154CAD527Q37060466-7FC693BD-0241-49A2-88CB-DF3DFFF0A5EBQ37626221-2A4B01AC-EA87-4295-8347-010148639456Q38220793-C4970F8A-AD63-4564-BFBD-D8A86799F020Q38382401-E9FB43E3-0401-42BC-9E7A-3D1C9B37B673Q38387942-A102FD3D-F344-45DF-B33B-178A6156BFB1Q38395249-4479DBC8-0215-4C7E-BEED-B6D6120C2CF6Q38941911-08F2BD90-32B0-420E-A405-A4361309B54FQ40449652-2E4C782B-FDB0-4C6D-93CB-AD99A30FCB79Q47236669-7E0C55B1-1D47-4192-9473-28CA7E1FA699Q48315757-80005441-01BD-4AD3-BB6F-D37A4991F85DQ52726708-2560F159-103D-4488-9F4D-5FD092BF7779
P2860
Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
@ast
Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
@en
type
label
Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
@ast
Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
@en
prefLabel
Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
@ast
Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
@en
P2093
P2860
P1476
Cancer susceptibility variants and the risk of adult glioma in a US case-control study
@en
P2093
Daniel J Brat
James E Browning
Jeffrey J Olson
Kathleen M Egan
Melissa H Madden
Paul L Moots
Reid C Thompson
Renato V Larocca
Steven Brem
Y Ann Chen
P2860
P2888
P304
P356
10.1007/S11060-010-0506-0
P577
2011-01-04T00:00:00Z